More importantly, in vivo assays further indicated that CBF could not only effectively inhibit colon tumor growth and metastasis but also significantly improve Oxa efficacy in colon tumors, which supported the promising potential of CBF as an emerging therapeutic for colon cancer. The gene discussed is CEBPZ; the disease is colonic neoplasm.